BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Sep 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-09-04

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-04	Common Stock	M	9000	$39.06	Acquired	46950	Direct
2013-09-04	Common Stock	S	9000	$69.00	Disposed	37950	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-04	Stock Option (right to buy)	$39.06	M	9000	Disposed	2022-05-28	Common Stock (9000)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 plan executed on May 10, 2013.

F2: Option grant vests 6/48ths on November 29, 2012 and 1/48th on the 29th day of every month thereafter.

F3: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.